Fingerprint
Dive into the research topics of 'Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab
Caridad Pontes*, Corinne Zara, Josep Torrent-Farnell, Merce Obach, Cristina Nadal, Patricia Vella-Bonanno, Michael Ermisch, Steven Simoens, Renata Curi Hauegen, Jolanta Gulbinovic, Angela Timoney, Antony P. Martin, Tanja Mueller, Anna Nachtnebel, Stephen Campbell, Gisbert Selke, Tomasz Bochenek, Celia C. Rothe, Ileana Mardare, Marion Bennie
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
23
Citations
(Scopus)